References: MHRA Yellow Card scheme (yellowcard.mhra.gov.uk)
Appetite suppression for most of the week, since this is a sign the medication is working at your current dose
Genetics: Variations in hormone receptor sensitivity and metabolic rate may affect response to triple agonist therapy, though evidence on genetic predictors is currently limited and emerging
The FDA, EMA, MHRA, TGA, and Health Canada cannot review a drug until Eli Lilly files an application, and Lilly has not filed
Seek immediate medical attention for any of these symptoms, alongside neck stiffness and headache: Suddenly, a severe headache is described as the worst of your life Vision changes, double vision, or loss of vision Weakness or numbness in arms or legs Difficulty speaking or understanding speech Loss of balance or coordination Headache after a head injury, especially with confusion Doctronic.ai can help quickly evaluate symptoms, but these warning signs always warrant an in-person emergency evaluation
Retatrutide reaches maintenance faster than tirzepatide